Nilkamal Limited has informed the Exchange about General Updates
NILKAMAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nilkamal's board approved audited financial results for Q4 and FY ended March 31, 2025. Standalone FY25 revenue grew ~3.4% YoY to Rs. 3,239 crores, but net profit declined ~15% to Rs. 91.27 crores (from Rs. 107.31 crores in FY24). Consolidated net profit also fell to Rs. 106.81 crores from Rs. 122.43 crores. The board recommended a final dividend of Rs. 20 per share (200%), subject to shareholder approval. Additionally, the company will acquire the healthcare business of Imedfurns Private Limited for Rs. 4 crores, payable over 4 years, to enter the healthcare furniture segment. The AGM is scheduled for July 18, 2025.
Shareholders will receive a strong 200% dividend, but the YoY profit decline (despite revenue growth) and worsening losses in the Retail & Ecommerce segment may concern investors. The small Rs. 4 crore healthcare acquisition is a minor diversification move and unlikely to materially impact near-term financials.